Fibroblast-to-cardiomyocyte lactate shuttle modulates hypertensive cardiac remodelling.
Fibroblast-to-cardiomyocyte lactate shuttle modulates hypertensive cardiac remodelling.
复制标题
DOI:
10.1186/s13578-023-01098-0
复制
发表时间:
2023-08-15
影响因子:
7.5
通讯作者:
Shen, Weili
中科院分区:
文献类型:
--
作者:
Wei, Tong;Guo, Yuetong;Huang, Chenglin;Sun, Mengwei;Zhou, Bin;Gao, Jing;Shen, Weili
Cardiac fibroblasts (CFs) and cardiomyocytes are the major cell populations in the heart. CFs not only support cardiomyocytes by producing extracellular matrix (ECM) but also assimilate myocardial nutrient metabolism. Recent studies suggest that the classical intercellular lactate shuttle may function in the heart, with lactate transported from CFs to cardiomyocytes. However, the underlying mechanisms regarding the generation and delivery of lactate from CFs to cardiomyocytes have yet to be explored. In this study, we found that angiotensin II (Ang II) induced CFs differentiation into myofibroblasts that, driven by cell metabolism, then underwent a shift from oxidative phosphorylation to aerobic glycolysis. During this metabolic conversion, the expression of amino acid synthesis 5-like 1 (GCN5L1) was upregulated and bound to and acetylated mitochondrial pyruvate carrier 2 (MPC2) at lysine residue 19. Hyperacetylation of MPC2k19 disrupted mitochondrial pyruvate uptake and mitochondrial respiration. GCN5L1 ablation downregulated MPC2K19 acetylation, stimulated mitochondrial pyruvate metabolism, and inhibited glycolysis and lactate accumulation. In addition, myofibroblast-specific GCN5L1-knockout mice (GCN5L1fl/fl: Periostin-Cre) showed reduced myocardial hypertrophy and collagen content in the myocardium. Moreover, cardiomyocyte-specific monocarboxylate transporter 1 (MCT1)-knockout mice (MCT1fl/fl: Myh6-Cre) exhibited blocked shuttling of lactate from CFs to cardiomyocytes and attenuated Ang II-induced cardiac hypertrophy. Our findings suggest that GCN5L1-MPC2 signalling pathway alters metabolic patterns, and blocking MCT1 interrupts the fibroblast-to-cardiomyocyte lactate shuttle, which may attenuate cardiac remodelling in hypertension. The online version contains supplementary material available at 10.1186/s13578-023-01098-0. 1. Ang II elevated lactate production during CFs differentiation into myofibroblasts. 2. GCN5L1-mediated MPC2K19 acetylation reduces MPC activity. 3. Acetylation of MPC2K19 alters CFs metabolic patterns. 4. Blocking MCT1 activity disrupts the lactate shuttle and attenuates cardiomyocyte hypertrophy. The online version contains supplementary material available at 10.1186/s13578-023-01098-0.
登录
查看更多内容
影响因子:
11.1
作者:
Li A;Liu Q;Li Q;Liu B;Yang Y;Zhang N
通讯作者:
Zhang N
影响因子:
20.1
作者:
Kaur, Harmandeep;Takefuji, Mikito;Wettschureck, Nina
通讯作者:
Wettschureck, Nina
影响因子:
4.1
作者:
Karsy, Michael;Guan, Jian;Huang, L. Eric
通讯作者:
Huang, L. Eric
DOI:
10.12659/msm.912735
发表时间:
2018-10-25
期刊:
Medical science monitor : international medical journal of experimental and clinical research
影响因子:
--
作者:
Deng Y;Li H;Yin X;Liu H;Liu J;Guo D;Shi Z
通讯作者:
Shi Z
影响因子:
3.2
作者:
Fu, Ze;Guo, Jiabin;Peng, Shuangqing
通讯作者:
Peng, Shuangqing